Effects of COVID-19 pandemic on hospital visit of head and neck cancer patients

Abstract

ObjectiveHead and neck cancer (HNC) often causes respiratory symptoms, so diagnostic delays due to COVID-19 are anticipated. Especially, our institute is a designated medical institute for Class 1 specified infectious diseases, and most of the severe COVID-19 patients in this region were preferentially admitted or transferred. Hereby, we evaluated the trends of the numbers, primary sites and clinical stages of HNC patients before and after COVID-19 pandemic. MethodsA retrospective analysis of all patients diagnosed and treated for HNC from 2015 to 2021 was performed. Especially, 309 cases between 2018 and 2021 were extracted in order to examine a direct impact of COVID-19 pandemic, which were dichotomized into “Pre” group in 2018–2019 and “COVID” group in 2020–2021. They were compared about the distribution of clinical stage, the period between onset of symptom and hospital visit. ResultsHNC patients decreased by 38% in 2020 and by 18% in 2021 compared to average number of patients from 2015 to 2019. Patients of stage 0 and 1 in “COVID” group significantly decreased compared to that in “Pre” group. Cases performed emergent tracheostomy in hypopharyngeal cancer and laryngeal cancer increased in “COVID” group (10.5% vs 1.3%). ConclusionPatients with slight symptoms would hesitated to visit hospital after COVID-19, and only a few delays of HNC diagnosis could have increased tumor burden and caused narrowed airway, especially in advanced HPC and LC.